• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Aurobindo Pharma Limited — Updates, 04-06-2026: Press Release

    04-06-2026 | 06:13 pm

    Aurobindo Pharma received US FDA approval for Tofacitinib Tablets (5mg & 10mg). This generic, bioequivalent to Xeljanz, targets a US market size of roughly US$ 49.4 Cr. The product will be launched immediately, boosting market presence.

    No comments yet. Be the first to comment!

    All announcements from Aurobindo Pharma Limited